Applications > Cell Therapy
Cell loading technologies are fundamental to modify the biological function of cells for cell-based therapeutics and gene therapy applications. The cell processing MaxCyte GT overcomes existing obstacles to cell therapy development with its high-volume, rapid and inherently safe technology that loads diverse cell types with nearly any molecule. For both autologous and allogeneic therapies, the MaxCyte GT can load cells to manipulate functionality; for example, delaying differentiation in stem cells, directing cells towards a desired pathway, producing a protein or eliciting/amplifying an immune response. The MaxCyte GT has received Master File designation with the CBER Division of the U.S. FDA and has been cleared by NIH's RAC and Health Canada.
MaxCyte Electroporation for Cell Therapy:
- A cGMP-compliant scalable therapeutic system
- A closed, controlled sterile system
- Avoidance of regulatory obstacles associated with current chemical transfection and viral vector technologies
- Increased throughput, cell-loading efficiency and viability without additional optimization
- Access to proven technology and authorization to reference FDA Master (CBER), cGMP protocol development, cell handling and optimization expertise
